Free CME from PeerView


Oncology CME

The Medical College of Wisconsin
CAR-T Cell Therapy: Are You Up to the Challenge? New Evidence and Best Practices Driving Modern Cellular Therapies as a Standard of Care for Leukemia and Lymphoma
Michael R. Bishop, MD
May 25, 2022
The Medical College of Wisconsin
Reaping the Rewards of Innovative Care in CLL: From Targeted Strategies to Cellular Therapy
John N. Allan, MD
May 24, 2022
The Medical College of Wisconsin
Overcoming the Challenges of Acute and Chronic GVHD: The Integration of Novel Therapies Into Modern Management Protocols
Leslie Kean, MD, PhD
May 19, 2022
The Medical College of Wisconsin
Landmarks Across the Patient Journey in AML: Applying Evidence With Novel Therapeutics Pre- and Post-AlloHCT
James M. Foran, MD, FRCPC
May 18, 2022
Medical Learning Institute, Inc.
Multidisciplinary Guidance on Translating the Latest Therapeutic Advances Into Patient Care for Early to Advanced Bladder Cancer: Clinical Consults and Cases From the Community
Ashish M. Kamat, MD, MBBS
May 14, 2022
Medical Learning Institute, Inc.
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans to Improve Outcomes in Resectable NSCLC
Nasser Altorki, MD
May 14, 2022
Penn State College of Medicine
Mapping the Therapeutic Odyssey in Multiple Myeloma: Interprofessional Guidance on Evidence-Based Treatment Selection and Sequencing
Nina Shah, MD
May 08, 2022
Medical Learning Institute, Inc.
Making Sense of the Evolving Treatment Landscape in Ovarian Cancer Care: Pharmacy Perspectives on PARP Inhibitor Therapy
Thomasina Morris, RPh, MHA, BCOP
May 06, 2022
Medical Learning Institute, Inc.
Making Sense of New Standards for CLL: Pharmacist Insights on Targeted Therapy and the Delivery of Team-Based Care
Amber C. King, PharmD, BCOP
May 05, 2022
PVI, PeerView Institute for Medical Education
Adapting to Innovation in Pediatric ALL: Guidance on Optimizing Modern Therapy and the Role of Novel Asparaginase Compounds
Stuart S. Winter, MD
May 04, 2022
PVI, PeerView Institute for Medical Education
Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interprofessional Insights on Optimizing Outcomes With Novel Targeted and Immune-Based Therapies
Nancy P. Moldawer, RN, MSN
April 30, 2022
PVI, PeerView Institute for Medical Education
Hope Is Here in CLL: Oncology Nurse Strategies for Delivering Effective, Compassionate, and Modern Care to Patients
Amy Goodrich, CRNP
April 28, 2022
Medical Learning Institute, Inc.
How to Harness Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer: New Goals and Better Tools to Close the Gaps
Erika Hamilton, MD
April 28, 2022
PVI, PeerView Institute for Medical Education
Tackling the Practicalities of Antibody–Drug Conjugate Therapy for Solid Tumors: Improving Clinical Care With HER2-, HER3-, and TROP2-Targeted Therapies
Linda Ahn, MSN, ANP-BC, AOCNP
April 27, 2022
PVI, PeerView Institute for Medical Education
Weighing the Evidence, Parsing the Practicalities: Integrating New Treatment Options Into the SCLC Treatment Arsenal to Improve Patient Outcomes in Oncology Practice
Jacob Sands, MD
April 26, 2022
The Medical College of Wisconsin
Upgrading the VOD/SOS Management Tool Kit: Guidance for Effective Diagnostic Confirmation, Grading, and Treatment
Nelson Chao, MD, MBA
April 26, 2022
PVI, PeerView Institute for Medical Education
Cancer Control Through Early Blood-Based Detection: Perspectives on Integrating Innovative Multicancer Early Detection Tests in the Primary Care Setting
John J. Russell, MD
April 21, 2022
PVI, PeerView Institute for Medical Education
Expanding Options, Lingering Questions: How to Select the Right Immunotherapy for First-Line Treatment of Advanced NSCLC
Mark A. Socinski, MD
April 19, 2022
PVI, PeerView Institute for Medical Education
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers
Prof. Solange Peters, MD, PhD
April 09, 2022
Medical Learning Institute, Inc.
Expanding the Benefits of PARP Inhibitors to More Patients With Breast Cancer and Earlier Settings
Henry M. Kuerer, MD, PhD, FACS
April 07, 2022
PVI, PeerView Institute for Medical Education
Cancer Screening and Preventive Care for Transgender Individuals: Patient and Provider Perspectives on Best Practices and Special Considerations
Elizabeth Eaman, MD
April 01, 2022
Medical Learning Institute, Inc.
Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Kurt A. Schalper, MD, PhD
March 22, 2022
Medical Learning Institute, Inc.
When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum
Bradley J. Monk, MD, FACS, FACOG
March 21, 2022
Medical Learning Institute, Inc.
Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do
Kurt A. Schalper, MD, PhD
March 21, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView